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Chromosome 22, particularly band 22q11.2, is predisposed to rearrangements due to misalignments of low-copy
repeats (LCRs). DiGeorge/velocardiofacial syndrome (DG/VCFS) is a common disorder resulting frommicrodeletion
within the same band. Although both deletion and duplication are expected to occur in equal proportions as
reciprocal events caused by LCR-mediated rearrangements, very few microduplications have been identiﬁed. We
have identiﬁed 13 cases of microduplication 22q11.2, primarily by interphase ﬂuorescence in situ hybridization
(FISH). The size of the duplications, determined by FISH probes from bacterial artiﬁcial chromosomes and P1
artiﬁcial chromosomes, range from 3–4 Mb to 6 Mb, and the exchange points seem to involve an LCR. Molecular
analysis based on 15 short tandem repeats conﬁrmed the size of the duplications and indicated that at least 1 of
15 loci has three alleles present. The patients’ phenotypes ranged from mild to severe, sharing a tendency for
velopharyngeal insufﬁciency with DG/VCFS but having other distinctive characteristics, aswell. Although the present
series of patients was ascertained because of some overlapping features with DG/VCF syndromes, the microdu-
plication of 22q11.2 appears to be a new syndrome.
Introduction
Susceptibility of the chromosome 22q11 region to rear-
rangements has been recognized on the basis of common
clinical disorders such as DiGeorge/velocardiofacial syn-
drome (DG/VCFS [MIM188400 andMIM192430]) and
cat-eye syndrome (MIM 115470), which are associated
with either decreased or increased gene dosage (Mc-
Dermid and Morrow 2002). The 22q11.2 microdeletion
syndrome, DG/VCFS, is the most common of these con-
ditions, representing a spectrum of clinical anomalies af-
fecting multiple organ systems including cardiovascular,
neurological, psychiatric, endocrinologic, and immuno-
logic. Palatal abnormalities and characteristic facial fea-
tures also can be present.
Recent evidence has implicated low-copy repeats
(LCRs) on 22q as mediators of nonallelic homologous
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recombination (NAHR) that result in rearrangements of
22q (Stankiewicz and Lupski 2002a). In theory, both
deletion and duplication events should occur in equal
proportions, as a result of NAHR caused by unequal
crossovers of LCRs. Surprisingly, carriers of duplication
of 22q11.2 are rarely reported (Taylor et al. 1977; Reiss
et al. 1985; Knoll et al. 1995; Lindsay et al. 1995; Prasher
et al. 1995; Fujimoto and Lin 1996; Meins et al. 2003).
Only one patient has been described with a “microdu-
plication” of this region: a 4-year-old child with mild
dysmorphism, developmental delay, and velopharyngeal
insufﬁciency (Edelmann et al. 1999b). Two other patients
have been described brieﬂy in abstracts (Hassed et al.
2002; Papenhausen et al. 2002).
Here, we report the phenotypic, cytogenetic, and mo-
lecular ﬁndings from 13 patients with new diagnoses of
variable microduplications of the 22q11.2 region, de-
ﬁning a new chromosomal microduplication syndrome.
The duplications range from ∼3 Mb (most common) to
∼4 Mb and ∼6 Mb within the 22q11.21-11.23 band.
Material and Methods
Clinical Evaluation
The phenotypic presentation of all reported index pa-
tients (tables 1 and 2) prompted clinical diagnostic con-
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Table 2
Dysmorphic Features Of Patients with 22q11.2 Microduplications
DYSMORPHIC
FEATURE
PATIENT
TOTAL1 2 3 4 5a 6 8 8M 8S1 8S2 9 10
Edelmann
et al.
(1999b)
Head:
Long narrow face              6/13
Bitemporal narrowing     ?         3/12
Microcephaly              2/13
Brachycephaly      ?        2/12
Mild micro-/retrognathia     ?         6/12
Eyes:
Superior placement of eyebrows              9/13
Ptosis     ?         3/12
Epicanthal folds     ?         2/12
Appearance of widely spaced eyes              9/13
Palpebral ﬁssures: ?
Upslanting    2/12
Downslanting           9/12
Ears:
Minor ear malformations  b c b  d ? e      5/12
Nose:
Large nose  f   f f     g   4/13
Hands/feet:
Abnormal palmar creases h  i j          3/13
Long ﬁngers and/or toes     ?         2/12
Brachydactyly     ?         3/12
NOTE.—Boldface italic type indicates that 150% of patients had the feature. No information on facial features was available for patient 7.
a Patient died at age 1 mo.
b Simpliﬁed ears.
c Slightly posteriorly rotated.
d Preauricular tag on the left; pit on the posterior right lobule.
e Prominent antihelix.
f Broad tip.
g Long and squared.
h Deep palmar creases.
i Not speciﬁed.
j Unilateral bridged palmar crease.
sideration of DG/VCFS. Patients 1, 2, 3, 4, 5, 6, and 8,
as well as the mother and two sisters of patient 8 (ﬁg.
1), were directly examined by at least one of the authors
(R.E., N.L., V.M., A.A.A., W.S., E.S.F., J.G., R.C., and
M.M.). Clinical information on patient 9 (ﬁg. 1) was
collected by review of medical records and by interview
of the patient’s primary care physician, after appropriate
consent was obtained from the patient’s parents. Limited
information was available on patients 7 and 10. The
patients’ parents gave written informed consent for pub-
lication of photographs. Mayo Clinic institutional re-
view board approval was obtained for extended labo-
ratory studies and publication.
Cytogenetic Analysis
Blood samples from 653 consecutive patients referred
to rule out DG/VCFS were processed by standard chro-
mosome and/or FISH procedures. At least 20 GTL-
banded (G bands by Giemsa, using Leishman’s stain)
metaphase cells were analyzed for each patient (ﬁg. 2).
FISH was performed using DNA ﬂuorescent probes for
the DG/VCFS critical region (TUPLE1 [MIM 600237])
at 22q11.2 and a control probe, arylsulfatase-A (ARSA
[MIM 607574]), at 22q13.3, from a commercially avail-
able source (Vysis). This is a direct-labeled dual-color
probe mixture with TUPLE1 (HIRA) probe labeled in
orange and ARSA probe labeled in green. Slide prepa-
ration, denaturation, hybridization, and posthybridiza-
tion washes were all performed according to already
established procedures (Crifasi et al. 1995) and the man-
ufacturer’s recommendations, with minormodiﬁcations.
For each patient, at least 100 interphase and 10 meta-
phase cells were scored for both the TUPLE1 and ARSA
signals. Those cases that did not have TUPLE1 deletion
were processed for microduplication of 22q11.2.
To establish a normal cutoff value for duplication in-
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Figure 1 A–F, Photographs of seven patients with 22q11.2 microduplications. For description of the patients’ main dysmorphic features,
see table 2. Additional dysmorphic stigmata of each patient are outlined here. A1 and A2, Patient 1 at age 11 mo, with ﬂat occiput, long
eyelashes, medial eyebrow ﬂaring, long philtrum, and a thin upper lip. Not shown: short frenulum of the tongue, narrow ear canals, persistent
ﬁngertip fat pads, and the vertical plantar crease between the ﬁrst and second toes, present bilaterally. B1 and B2, Patient 2 at age 18 years,
with a relatively large mouth, posteriorly sloping forehead, slightly overfolded ears, thick eyebrows, and alopecia due to anX-linked hypotrichosis
syndrome, which was also present in his mentally normal brothers. C1 and C2, Patient 3 at age 7 mo. Not shown: protruding tongue and ﬁfth-
ﬁnger clinodactyly. D1 and D2, Patient 4 at age 6 years. Not shown: extremely high arched palate, three cafe´-au-lait macules (!0.5 cm). E1,
Patient 8 at age 10 years. He had surgery for left ptosis at age 5 years. E2, Mother of patient 8, at age 31 years. F1, Patient 9 at age 12 years.
F2, Patient 9 at age 9.5 mo. Not shown: distal placement of the thumb with decreased abduction.
volving TUPLE1, the probe was hybridized to interphase
cells from 10 unaffected individuals, and 200 cells were
scored for both the TUPLE1 and ARSA signals in each
of these samples. Strict scoring criteria were applied dur-
ing the analysis of interphase cells, to differentiate be-
tween fragmented/split probe signals and duplicated
critical region probe signals, thereby eliminating false
positives. Duplication was ruled out if split TUPLE1
signals were present with split ARSA signals, if split TU-
PLE1 signals were not equal in size and intensity with
the third TUPLE1 signal, or if split TUPLE1 signals had
a visible connecting strand. On the other hand, if the
split TUPLE1 signals were equal in size and intensity
with the third TUPLE1 signal and if a signal of equal
size could ﬁt in-between, the cell was scored as a du-
plication (ﬁg. 3). On the basis of the highest proportion
of abnormal signal, a normal cutoff of 11.5% was es-
tablished at a 95% CI from a one-sided binomial dis-
tribution. A sample with duplication therefore needs to
have 111.5% nuclei with three TUPLE1 signals. Ten
metaphases (ﬁg. 3) were examined to conﬁrm the inter-
phase ﬁnding in each case, but duplication in the meta-
phase nuclei is very difﬁcult to detect; therefore, the pri-
mary criteria used for diagnosis of duplication were
based on the analysis of interphase FISH (table 3). When
possible, family members of patients with the 22q11.2
duplication were also analyzed.
Molecular Cytogenetic Analysis
To estimate the size of the 22q11.2 duplications in
each patient, 25 direct-labeled FISH probes (20 were
informative) were designed from BACs and PACs span-
ning regions centromeric and telomeric to TUPLE1. The
search for BACs and PACs in the region of interest on
22q11.2 was accomplished using the University of Cal-
ifornia Santa Cruz (UCSC) Genome Browser (UCSCGe-
nome Bioinformatics Home Page). Clones were selected
on the basis of their location, such that each clone
ﬂanked or overlapped the next clone. Stab cultures of
the BAC and PAC clones were received from Dr. B. Roe
of the Department of Chemistry and Biochemistry, Uni-
versity of Oklahoma. Clones were plated and propa-
gated immediately upon arrival, and glycerol stockswere
prepared. Isolation and puriﬁcation of DNA were per-
formed, using the QIAGEN Plasmid Maxi Kit (25), ac-
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Figure 2 G-banded chromosome 22 pair from patient 8, at different band resolutions. The chromosome with dup(22)(q11.2) is to the
right in each pair. The dup(22)(q11.2) is readily visible at the 850-band stage (arrow).
cording to manufacturer’s instructions. The sequences
for the BACs and PACs were obtained from theNational
Center for Biotechnology Information (NCBI) Web site.
After editing out repetitive sequences through use of the
CENSOR server (Genetic Information Research Institute
Web site), primers were designed for each BAC and PAC
clone, and unique sequences were ampliﬁed by PCR to
verify the identity of the clone.
Nick translation was performed using the Vysis Nick
Translation Kit (Vysis) to produce the ﬂuorescence-la-
beled DNA probes for FISH. Probes were labeled with
Spectrum Orange-dUTP or Spectrum Green-dUTP, pre-
cipitated, and applied to metaphase cells from normal
blood specimens, to verify hybridization to the region
on 22q and the lack of hybridization to other sequences.
The validated probes were then sequentially applied to
interphase and metaphase cells from the 13 patients, as
described for the TUPLE1 probe above. The status of
each probe was determined from the analysis of signals
from 100 interphase cells and 10 metaphase cells from
each of the patients.
Molecular Analysis: Polymorphism Analysis Using STR
Markers
Genomic DNA was extracted, from peripheral white
blood cells that were either freshly obtained or ﬁxed in
methanol/acetic acid, through use of either the Qiagen
protocol (Qiagen) or the Puregene protocol (Gentra Sys-
tems). Polymorphism data were collected using a panel
of 15 STR ﬂuorescent markers (D22S420, D22S427,
D22S1638, D22S941, D22S1648, D22S944, D22S1623,
D22S264, D22S311, D22S1709, D22S308, D22S306,
D22S425, D22S303, and D22S257). All of the primer
sequences for the polymorphic markers were obtained
from The Genome Database, except for D22S420, which
is from the ABI PRISM Linkage Mapping Set (Applied
Biosystems). The forward primer for each marker was
labeled with either 6-FAM or NED, and PCR was per-
formed using conditions optimized for each marker. The
ampliﬁed products were diluted with water, to obtain a
ﬂuorescent signal strength of 1,000–6,000 relative ﬂuo-
rescence units, and were analyzed on an ABI PRISM3100
using Genotyper 3.7 software (Applied Biosystems). Du-
plication was noted whenever three distinct alleles were
present. If only two alleles were present, dosage analysis
was performed to determine whether duplication was
present, by comparing the ratio of the peak areas with
the ratio obtained from known control samples (Kre-
pischi-Santos and Vianna-Morgante 2003).
Results
Over a 1-year period, blood samples from 653 consec-
utive patients who were referred to rule out DG/VCFS
were processed for standard chromosome and/or FISH
analysis, to detect deletion or duplication of 22q11.2.
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Figure 3 A, Interphase cell from patient 1, showing duplication of TUPLE1 (three red signals) and two control probe (ARSA) signals (green).
B, Metaphase cell from patient 1, showing microduplication of TUPLE1 (red) on one chromosome 22 (arrow) and normal control probe, ARSA
(green). The microduplication is seen as a larger-sized signal compared with the normal, although the distinction was often difﬁcult, underscoring
the importance of interphase FISH analysis. C, FISH with probes prepared from BACs centromeric to HIRA. Interphase cells from patient 2 are
shown, showing two signals for b476c20 (green) (base pair positions 16796870–16971860) and three signals (duplication) for bac519d21 (red)
(base pair positions 16926349–17071935). A metaphase cell shows the same duplication on one chromosome 22 (arrow). Overlap of the green
and red signals is seen as a yellow signal. Bac519d21 marks the proximal breakpoint of the 22q11 duplication in all 13 patients. D, E, and F, FISH
with probes prepared from clones telomeric to HIRA. D, Interphase cells from patient 7 with a ∼3-Mb duplication, showing duplication of b135h6
(red) (base pair positions 19443166–19678560) and normal signal pattern for RP11-36N5 (green) (base pair positions 20289389–20343913).
Overlap of the red and green signals is seen as a yellow signal. E, Interphase cells from patient 8 with a ∼4-Mb duplication, showing duplication
of CTA-526G4 (green) (base pair positions 20712617–20712739) and normal signal pattern for 865e9 (red) (base pair positions 21687068–
21830046). F, Interphase cells from patient 10 with a ∼6-Mb duplication, showing duplication of RP11-76E8 (red) (base pair positions 22813079–
22989794) and normal signal pattern for RP3-370D16 (green) (base pair positions 23137821–23137941).
Samples were initially screened for deletion of 22q11.2.
A total of 13 patients (2%) were identiﬁed with micro-
duplication. The clinical ﬁndings for the patients are
presented in tables 1, 2, and 4. The details of laboratory
ﬁndings corresponding to each case are summarized in
tables 1, 3, 5, and 6. Age at diagnosis ranged from new-
born to 18 years of age, with 54% of patients being
male. Microduplication 22q11.2 was de novo in ﬁve of
seven cases.
Phenotype
The distinctive facial characteristics observed in more
than half of the patients were superior placement of
eyebrows and widely spaced eyes with downslanting pal-
pebral ﬁssures (table 2). Mild micro-/retrognathia and
minor ear anomalies were seen in 50% and 45% of
patients, respectively. Forty-six percent of patients had
a long, narrow face. Velopharyngeal incompetence was
present in 70% (7/10) of patients, with cleft palate in
ﬁve subjects (table 1). Seventeen percent (2/12) of pa-
tients had congenital heart defects; one of these two pa-
tients had Fallot tetralogy, and the other had hypoplastic
left heart syndrome and interrupted aortic arch. Forty-
two percent (5/12) of patients had hearing loss; one of
these ﬁve patients had conﬁrmed conductive hearing
loss, whereas the exact type of hearing loss was not
available in the other cases. Malformations of the uro-
genital tract were diagnosed in 46% (5/11) of patients;
two of these patients had urethral stenosis. Twenty-ﬁve
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Table 3
Fluorescence In Situ Hybridization of 13 Patients with
Microduplication of 22q11.2
Patient
No. of Interphase
Cells with
dup(22)(q11.2q11.2)/
Total Cells
No. of Metaphase
Cells with
dup(22)(q11.2q11.2)/
Total Cells
1 87/100 11/11
2 84/100 4/10
3 87/100 10/10
4 85/100 13/13
5 83/100 20/50
6 98/100 8/11
7 70/100 7/11
8 70/100 10/10
8M 155/200 0/10
8S1 87/100 0/10
8S2 81/100 0/10
9 161/200 10/10
10 81/100 4/10
Table 4
Comparison of 22q11.2 Deletion and Duplication Disorders
SYMPTOM
% (FRACTION) WITH SYMPTOM IN
Microduplication
22q11.2
Large Interstitial
Duplication 22q11a
Cat-Eye
Syndromeb
Microdeletion
22q11.2c
Cognitive deﬁcits 100 (11/11) 100 (7/7) 56 (38/68) 90–100
Downslanting palpebral ﬁssures 75 (9/12) 71 (5/7) 69 (48/70) Not characteristic
Urogenital malformations 46 (5/11) 57 (4/7) 71 (55/77) 37 (25/67)
Hearing loss 42 (5/12) 33 (1/3)d 16 (11/68) 39 (19/49)
Cleft palate or absent uvula 39 (5/13) 0 (0/7) 31 (15/48) 32 (75/234)
Conotruncal heart defectse 17 (2/12)f 0 (0/7) 9 (7/80) 38 (116/305)
Other heart defects 8 (1/12)f 50 (3/6)d 88 (70/80) 37 (113/305)
Preauricular malformations 8 (1/12) 71 (5/7) 87 (78/90) Not characteristic
Immunodeﬁciency 8 (1/12) Not characteristic Not characteristic 77 (46/60)
Anorectal malformations 0 (0/13) 14 (1/7) 81 (71/88) Rarely reportedg
Ocular coloboma 0 (0/13) 43 (3/7) 61 (54/88) Rarely reportedh
Hypocalcemia Not detected Not detected Not detected 49 (77/158)
a Data are from Taylor et al. (1977), Reiss et al. (1985), Knoll et al. (1995), Lindsay et al. (1995), Prasher et al.
(1995), Fujimoto and Lin (1996), and Meins et al. (2003). Duplication sizes ranged from 22q11.1-q11.2 to 22q11-
q13.
b Data are from Rosias et al. (2001).
c Data are from Emanuel et al. (2001).
d Information was not available in all cases.
e At least one of each of the following: tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus.
f One patient had hypoplastic left heart syndrome and interrupted aortic arch.
g From Worthington et al. (1997).
h From Goldberg et al. (1993).
percent of patients had other signiﬁcant malformations,
including absent thymus, asplenia, and intestinal mal-
rotation. Fifty-eight percent of patients had low weight
or poor growth, and one required a feeding tube. Cog-
nitive impairment was quite variable, but all patients
that could be evaluated had cognitive deﬁcits of some
degree. One patient had a seizure disorder, although
three more had deﬁnitely or possibly abnormal EEG
results.
The following two cases exemplify the widely variable
phenotype of microduplication 22q11.2 syndrome. Pa-
tient 5 (tables 1 and 2) had the most severe clinical pre-
sentation. At birth, he received a diagnosis of hypoplastic
left heart syndrome and interrupted aortic arch. Addi-
tional malformations included absent thymus, asplenia,
mild left hydronephrosis, and grade I hypospadias. Be-
cause of immunodeﬁciency and recurrent episodes of sep-
sis, he was not considered a suitable candidate for surgical
procedures at his local institutions. He died of cardiac
complications at 1 mo of age. In contrast, patient 8, with
familial microduplication 22q11.2 (tables 1 and 2),
showed a quite different phenotype, including mental re-
tardation, microcephaly, and aggressive behavior. Except
for ptosis and mild hydronephrosis, he had no malfor-
mations. There was considerable intrafamilial variability
of the condition. The two affected sisters had learning
disabilities. In addition, one had a cleft palate and the
other had poor growth. The affected mother also had
learning problems. She had a kidney anomaly requiring
surgery in childhood.
Cytogenetic Findings
Microduplication of 22q11.2 was observed in 13 pa-
tients, 10 of whom were unrelated and 3 of whom were
related to 1 of the 10 (a mother and two siblings; see
tables 1, 2, and 3). Microduplication of 22q11.2 was
observed or suspected in four of nine (one was not avail-
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Table 5
Individual FISH Results of Probes from Clones on 22q11.2 for 13 Patients
CLONE (GENBANK
ACCESSION NUMBER) BASE PAIR POSITIONa
CHROMOSOME
BAND
FISH RESULTS IN PATIENTb
1 2 3 4 5 6 7 8 8M 8S1 8S2 9 10
b476c20 (AC016027) 16796870–16971860 22q11.21             
b677f7 (AC008101) 16893710–17021443 22q11.21             
bac519d21 (AC008079) 16926349–17071935 22q11.21             
pac995o6 (AC008132) 17071632–17217229 22q11.21             
p423 (AC007326) 17263867–17366764 22q11.21             
72f8 (AC000085) 17621007–17721158 22q11.21             
TUPLE1 (HIRA) 17692778–17793801 22q11.21             
p888c9 (AC005663) 18308259–18411380 22q11.21             
b444p24 (AC007663) 18515763–18684001 22q11.21             
562f10 (AC007731) 19028370–19204493 22q11.21             
bac32 (AC007050) 19230748–19394655 22q11.21             
b135h6 (AC002470) 19443166–19678560 22q11.21             
RP11–36N5 20289398–20343913 22q11.21        NT NT NT NT NT NT
RP11–22M5 20564423–20761060 22q11.22        NT NT NT NT NT NT
CTA-526G4 20712617–20712739 22q11.22             
865e9 (AC000029) 21687068–21830046 22q11.22             
605b (AC000102) 21829574–21833044 22q11.23             
RP11–76E8 22813079–22989794 22q11.23 NT NT NT NT NT NT NT NT NT NT NT  
RP3–370D16 23137821–23137941 22q11.23 NT NT NT NT NT NT NT NT NT NT NT  
RP5–930L11 23510702–23645658 22q11.23 NT NT NT NT NT NT NT NT NT NT NT  
Estimated duplication size (Mb) 3 3 3 3 3 3 3 4 4 4 4 6 6
a NCBI Homo sapiens genome view, build 33 (NCBI Map Viewer Web site).
b  p normal signal pattern;  p duplication; NT p not tested.
able for chromosome analysis) unrelated patients, on the
basis of 550–675-band-stage karyotype analysis (table 1).
However, at the 750–850-band stage, the duplicationwas
detectable in all eight patients available to us for chro-
mosome analysis (ﬁg. 2). By interphase FISH (ﬁg. 3), the
duplication was detected with ease in all 13 patients.
However, the detection of the duplication by metaphase
FISH was inconsistent, ranging from 0/10 to 13/13 cells
analyzed (table 3). The duplication was detectable on
longer chromosomes, where they were not seen by routine
metaphase FISH analysis. Analysiswith FISHprobes from
BACs and PACs indicated the involvement of the same
LCR at the centromeric end, but the telomeric end of the
duplication varied, resulting in duplication sizes ranging
from ∼3 Mb to 6 Mb (table 5; ﬁg. 4).
Molecular Analysis
Results of haplotype analysis using 15 STR markers
speciﬁc for genomic region 22q11.2 were consistentwith
microduplication in 12 patients tested (table 6). The
proximal breakpoint was similar in all 12 patients and
was mapped between D22S427 and D22S1638. The dis-
tal breakpoint was between D22S1709 and D22S308 in
six patients, between D22S306 and D22S425 in four
patients (a mother and three children), and through
D22S257 in two other patients. All 12 patients dem-
onstrated at least one marker with three alleles through
the duplicated region, with the majority of patients hav-
ing three to ﬁve markers showing three alleles. Markers
that demonstrated two alleles were subjected to dosage
analysis to determine whether duplication was present
(ﬁg. 5). The haplotype analysis of three generations of
patient 8 showed that the duplication originated in his
maternal grandfather (ﬁg. 6).
Discussion
In this investigation, patients who were referred to rule
out 22q11.2 microdeletion diagnostic of DG/VCFS were
included if the critical-region microdeletion result of
metaphase FISH analysis was normal. This study sug-
gests that microduplications of 22q11.2 are relatively
common and probably have been underdiagnosed. Use
of interphase FISH analysis was primarily responsible
for the diagnosis, since routine chromosome analysis can
easily miss the duplication. Theoretically, a frequency
similar to that of DG/VCFS, 1:4,000–1:6,000 (Shaffer
and Lupski 2000; Botto et al. 2003; Kato et al. 2003),
is anticipated. By use of interphase FISH and cytogenetic
analysis, 13 patients (10 unrelated) with a microdupli-
cation of 22q11.2 were identiﬁed within 1 year (13/653,
or 2% of referrals for deletion of 22q11.2). Within the
same period, microdeletions of 22q11.2 (DG/VCFS)
were diagnosed in 40 patients (6.1%).
The clinical phenotype of patients in this series with
the “22q11.2 duplication syndrome” appears variable,
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Table 6
Microsatellite Analysis of 22q11.2 Microduplication Involving 12 Patients
DNA
MARKER
POSITION
ON
UCSC
PHYSICAL
MAP
(Mb)
ALLELE(S) IN PATIENTa
1 2 3 4 5 6 8 8M 8S1 8S2 9 10
D22S420 16.23 2, 3 4, 5 NA 2, 3 2, 4 2, 3 2, 3 2, 2 2, 3 2, 4 2, 3 3, 4
D22S427 16.97 4, 7 3, 4 2, 2 2, 7 6, 7 2, 7 2, 4 2, 4 2, 4 4, 5 2 (NI) 2, 7
D22S1638 17.37 1, 3, 3 2, 3, 6 NA 5 (NI) 2 (NI) 3, 5 3, 3, 4 1, 3, 4 3, 3, 4 2, 3, 4 3, 3, 7 2, 3, 4
D22S941 17.78 2 (NI) 1, 2, 6 NA 2, 2, 5 3, 4, 5 2, 5, 7 2, 2, 3 1, 2, 3 2, 2, 3 1, 2, 3 2, 2, 3 1, 1, 2
D22S1648 17.18 1 (NI) 1 (NI) NA 1 (NI) 3, 4, 5 1 (NI) 1, 2, 3 1, 1, 3 1, 2, 3 1, 1, 3 1 (NI) 1 (NI)
D22S944 17.98 2, 2, 5 1, 2, 5 1, 1 1, 1, 2 2 (NI) 2, 2, 3 1, 2 2, 3 1, 2 2 (NI) 1, 2, 3 2, 4, 4
D22S1623 18.02 1, 2, 3 2, 2, 3 NA 2, 2, 3 3, 5, 5 2, 3 1, 4, 4 2, 4, 4 1, 4, 4 1, 4, 4 NA NA
D22S264 19.10 NA 1, 2, 5 1, 2, 7 2, 5, 7 3, 7, 8 3, 7, 8 2, 3, 5 2, 3, 5 2, 3, 5 2, 3, 4 2, 6, 7 2, 2, 6
D22S311 19.50 1, 2, 4 3, 3, 5 NA 1, 3, 5 1, 4, 4 3, 5, 5 1, 2, 3 1, 2, 1 1, 2, 3 1, 2, 3 1, 2, 4 1, 1, 3
D22S1709 19.74 1, 2, 3 5, 5, 6 NA 2, 5, 7 1, 4, 4 1, 2, 3 1, 2, 3 1, 2, 3 1, 2, 3 1, 1, 3 4 (NI) 1, 2, 5
D22S308 20.83 3 (NI) 1, 3 NA 1, 3 3 (NI) 1, 3 1, 3, 3 1, 3, 3 1, 3, 3 3 (NI) 1, 3, 3 1, 1, 3
D22S306 20.89 NA 2, 4 1, 2 1 (NI) 2, 3 1, 2 1, 2, 2 2 (NI) 1, 2, 2 1, 2, 2 1, 3, 3 3 (NI)
D22S425 21.41 1, 4 2, 6 NA 1, 7 1, 4 1 (NI) 1, 3 1, 3 1, 3 1, 2 1, 3, 5 2, 2, 4
D22S303 21.60 1, 2 3 (NI) NA 1, 2 1, 2 2, 3 1, 3 1, 3 1, 3 1, 4 1, 2, 3 1, 2, 2
D22S257 21.89 1, 4 1, 5 NA 4 (NI) 1, 4 1, 4 1, 3 1, 4 1, 3 1, 3 1, 3, 4 1, 4, 4
a NI p noninformative; NA p no ampliﬁcation.
ranging from mild learning disabilities as the only symp-
tom to the presence of severe congenital malformations
leading to early death (tables 1 and 2; ﬁg. 1). Multiple
organ systems can experience effects; these effects include
hearing loss, congenital heart defects, growth deﬁciency,
and global developmental delays. Two patients showed
conotruncal defects commonly seen in patients with DG/
VCFS (Emanuel et al. 2001). Certain clinical symptoms,
such as palatal clefting/insufﬁciency or thymus aplasia,
are features also observed in patients with DG/VCFS. In
all 10 unrelated patients, DG/VCFS was clinically sus-
pected, either because of the patient’s clinical presenta-
tion and/or a family history suggestive of an underlying
22q11.2 microdeletion. Because this series of patients
was ascertained as suspected DG/VCFS cases, the group
may be biased toward DG/VCFS-like features. A pro-
spective study without this inherent bias could produce
different frequencies of associated anomalies.
We suggest that the following features may be asso-
ciated with the condition: appearance of widely spaced
eyes and superior placement of eyebrows—that is, in-
creased distance from eyebrow to upper eyelid crease;
downslanting palpebral ﬁssures with or without ptosis;
mild micro-/retrognathia; and a long, narrow face. These
ﬁndings are different from dysmorphism observed in pa-
tients with DG/VCFS. Of note, infants might not present
with the same phenotypic features as older children (ﬁg.
1). Since the clinical presentation can be mild and facial
features can be divergent from those of DG/VCFS, many
patients with the disease might be without diagnoses.
It is interesting that one patient presented with preaur-
icular tags and pits, which have been reported to be the
most consistent ﬁnding in cat-eye syndrome (Rosias et
al. 2001). Likewise, most patients with an interstitial mi-
croduplication or large duplication of 22q11 presented
with downslanting palpebral ﬁssures, which is a frequent
feature in cat-eye syndrome but not in 22q11.2 micro-
deletion syndrome. However, other ﬁndings associated
with cat-eye syndrome, such as anorectal anomalies and
ocular coloboma, were not observed in our series of pa-
tients (table 4).
Marked inter- and intrafamilial variability is observed
among patients with 22q11.2 microduplications. Dif-
ferent degrees of mental impairment, for example, may
be present within the same family despite the family
members having the same duplication size. Two of seven
of the presented cases in which parents have been tested
were familial (table 1). The recurrence risk of 50% for
each child of an affected parent may result in multiple
affected family members and, thus, make this disorder
a signiﬁcant health concern. Early and precise diagnosis
of the condition is imperative to provide adequate ge-
netic counseling.
Chromosome-banding studies at !550-band resolu-
tions may not always reveal microduplication of chro-
mosome 22q11.2, since the microduplication is in a
light-banded region. Among the nine patients studied
chromosomally, the dup(22)(q11.2) was identiﬁed from
550–675-band resolution G-banded karyotypes in two
patients and was suspected in two other patients (table
1). The microduplication was, however, visible at higher
resolution (750–850-band stage) in all of the studied
patients (ﬁg. 2). Since 750–800-band-resolution karyo-
types are not routinely analyzed, FISH studies of inter-
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Figure 4 Comparison of the microduplication breakpoints determined by BAC and PACmapping of 22q in 13 patients with dup(22)(q11.2)
with the proximal and distal LCRs (denoted by boxes marked “A” and “B,” respectively) of the 3-Mb DG/VCFS deletion. Boxes marked “C,”
“D,” and “E” indicate other documented 22q11.2 LCRs, which are telomeric to the distal LCR (B). BAC519d21 marks the proximal breakpoint
of the duplicated segment of 22q11.2 in all 13 patients. The distal breakpoints were between b135h6 and RP11-36N5 for ∼3-Mb duplications,
between CTA-526G4 and 865e9 for ∼4-Mb duplications, and between RP11-76E8 and RP3-370D16 or RP5-930L11 for ∼6-Mb duplications.
Seven patients had ∼3-Mb duplications, whereas four and two had ∼4 Mb and ∼6 Mb duplications, respectively. Numbers in brackets indicate
the base pair positions of the genetic markers. Information used for the ﬁgure was obtained from Collins et al. (1997), McTaggart et al. (1998),
Edelmann et al. (1999b), and NCBI Map Viewer (Build 33, April 2003).
phase nuclei play a key role in the identiﬁcation of pa-
tients with dup(22)(q11.2).
Interphase FISH detected the duplication in all pa-
tients, but it was conﬁrmed by metaphase FISH in all
but three patients. An average of 90% of interphase
cells showed three TUPLE1 signals, whereas the micro-
duplication ranged from 0% to 100% in metaphase
cells (table 3). This again underscores the need for high-
resolution chromosomes in the identiﬁcation of micro-
duplications, both for G-banded analysis and meta-
phase FISH, which may not be practicable in all cases.
Recently, it was demonstrated that repetitive DNA se-
quences—namely, the region-speciﬁc LCRs—are pres-
ent at the breakpoints of common chromosome 22 re-
arrangements as well as at the breakpoints of common
rearrangements involving other chromosomes (Edel-
mann et al. 1999a, 1999b; Shaffer and Lupski 2000;
Shaikh et al. 2000, 2001; Stankiewicz and Lupski
2002b). Since LCRs are involved in the interstitial de-
letion of 22q11.2 resulting in DG/VCFS, and because
of the relative frequencies of this disorder, one would
expect that the reciprocal microduplication 22q11.2
would be of similar frequency. The paucity of reported
cases of 22q11.2 microduplications likely reﬂects a lim-
itation in the techniques used to detect microdeletions
and/or the mild nature of anomalies in some patients.
In an effort to determine the sizes of duplications in
the 13 patients, FISH analyses using BAC and PAC
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Figure 5 Dosage analysis used to determine duplication size by microsatellite analysis for the family with a ∼4-Mb duplication. Ratios
(area 1/area 2) were calculated from the areas under each peak for the patient samples and a negative control with the same peak pattern. A,
Marker D22S306; ratios vary more than twofold, indicating duplication of allele 2. B, Marker D22S425; ratios are identical for the patient
and the negative control, indicating that no duplication is present. X-axis: time in seconds; Y-axis: RFUs.
probes on 22q that were centromeric and telomeric to
HIRA were performed and showed that all 13 patients
had the same centromeric duplication breakpoint. The
distal portion of bac519d21 delineates this centromeric
breakpoint and maps to the proximal LCR implicated in
the 3-Mb DG/VCFS deletion (McTaggart et al. 1998;
Edelmann et al. 1999a, 1999b; Shaffer and Lupski 2000;
Shaikh et al. 2000, 2001; Stankiewicz and Lupski 2002b)
(ﬁg. 4). This LCR lies in the interval between the genetic
markers D22S427 and D22S36/D22S1638 (Carlson et
al. 1997; Edelmann et al. 1999a, 1999b). Telomeric to
HIRA, however, the breakpoints of themicroduplications
appear to be different. Seven of the patients had a distal
breakpoint between the genetic markers D22S1709
(CRKL [MIM 602007]) and D22S308, which bound the
distal LCR implicated in the 3-Mb DG/VCFS deletion,
suggesting that these patients have an ∼3-Mb–sized
duplication, which is similar in size to the deletion in
22q11.2 microdeletion syndromes.
The hybridization pattern in patient 8 and his mother
and two sisters revealed a distal duplication breakpoint
suggestive of a duplicated segment ∼4 Mb in size,
whereas patients 9 and 10 had patterns suggestive of a
microduplication size of ∼6 Mb (table 5; ﬁg. 4). In ad-
dition to the proximal and distal LCRs implicated in
the DG/VCFS 3-Mb deletion, other LCRs telomeric to
the distal DG/VCFS LCR were recently identiﬁed on
22q (Edelmann et al. 1999a, 1999b). The presence of
larger duplications, ∼4 Mb in four of the patients and
∼6 Mb in two of the patients, is an indication that these
other LCRs, too, play an important role in rearrange-
ments involving 22q.
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Figure 6 Results of genotyping of patient 8 and relevant family members through use of a panel of STR markers. Haplotype analysis
indicates that the duplication occurred in the germline of the maternal grandfather.
Results of molecular analysis based on a panel of 15
STRs are in general agreement with the ﬁndings based
on BACs and PACs. Through molecular analysis, we
also discovered that each of the cases had three alleles
for at least one STR (table 6; ﬁg. 6). This would suggest
that each of the microduplications observed was a seg-
mental heterodisomy originating in the ﬁrst meiotic di-
vision, although a precocious separation of sister chro-
matids in the ﬁrst division of meiosis can also provide
the same results. LCR-mediated microdeletion and mi-
croduplication are well documented for 17p, as well
(Chance et al. 1994; Potocki et al. 2000). Recently, a
family with three generations has been described in
which the microduplication of 15q11.2-13 involved
both maternal homologues in its origin from unequal
crossing over in meiosis I, similar to our ﬁnding (Tho-
mas et al. 2003).
The microdeletion sizes of 22q11.2 have ranged from
3 Mb (190%) to 2 or 2.5 Mb, on the basis of 250 cases
(Carlson et al. 1997; Kato et al. 2003), which implies
that deletions 13 Mb are not tolerated. Since we are
reporting microduplication sizes of 4 Mb and 6 Mb as
well—although 3 Mb is most common—microdupli-
cations may prove to be more common than microde-
letions. Our preliminary results do not support a cor-
relation between the size of the duplication and the
severity of the phenotypic presentation. This suggests
that, in addition to gene dosage, other mechanisms—
such as genetic and/or environmental interactions and,
possibly, imprinting—may be important in determining
the phenotypic outcome of patients with 22q11.2
microduplication.
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